메뉴 건너뛰기




Volumn 69, Issue 12, 2014, Pages 3409-3422

Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: Antimicrobial non-susceptibility among 108717 clinical isolates from primary, secondary and tertiary care patients in London

Author keywords

Antibiograms; Antimicrobial stewardship; Healthcare associated infections; Multidrug resistant organisms

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAMASE AMPC; CIPROFLOXACIN; ERTAPENEM; MEROPENEM; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM;

EID: 84926477906     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku307     Document Type: Article
Times cited : (37)

References (36)
  • 1
  • 2
    • 77956059238 scopus 로고    scopus 로고
    • Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital-and communityacquired infection
    • Lamoth F,Wenger A, Prod'hom G et al. Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital-and communityacquired infection. Infection 2010; 38: 249-53.
    • (2010) Infection , vol.38 , pp. 249-253
    • Lamoth, F.1    Wenger, A.2    Prod'hom, G.3
  • 3
    • 77955289819 scopus 로고    scopus 로고
    • Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum b-lactamase-and metallo-b-lactamase-producing Gram-negative bacteria-an Indian experience
    • Azim A, Dwivedi M, Rao PB et al. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum b-lactamase-and metallo-b-lactamase-producing Gram-negative bacteria-an Indian experience. J Med Microbiol 2010; 59: 955-60.
    • (2010) J Med Microbiol , vol.59 , pp. 955-960
    • Azim, A.1    Dwivedi, M.2    Rao, P.B.3
  • 4
    • 34247533752 scopus 로고    scopus 로고
    • Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia
    • Verhamme KMC, De Coster W, De Roo L et al. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia. Infect Control Hosp Epidemiol 2007; 28: 389-97.
    • (2007) Infect Control Hosp Epidemiol , vol.28 , pp. 389-397
    • Verhamme, K.M.C.1    De Coster, W.2    De Roo, L.3
  • 5
    • 85043551113 scopus 로고    scopus 로고
    • ICU-always the hotbed of resistance?
    • Reynolds R, Maher K, Hope R on behalf of BSAC Working Party on Resistance Surveillance. ICU-always the hotbed of resistance? Clin Microbiol Infect 2011; 17 Suppl S4: S333 (P1231).
    • (2011) Clin Microbiol Infect , vol.17 , pp. S333
    • Reynolds, R.1    Maher, K.2    Hope, R.3
  • 6
    • 20444502169 scopus 로고    scopus 로고
    • Nationwide antibiogram analysis using NCCLS M39-A guidelines
    • Zapantis A, Lacy MK, Horvat RT et al. Nationwide antibiogram analysis using NCCLS M39-A guidelines. J Clin Microbiol 2005; 43: 2629-34.
    • (2005) J Clin Microbiol , vol.43 , pp. 2629-2634
    • Zapantis, A.1    Lacy, M.K.2    Horvat, R.T.3
  • 8
    • 33747692208 scopus 로고    scopus 로고
    • Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy
    • Binkley S, Fishman NO, LaRosa LA et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol 2006; 27: 682-7.
    • (2006) Infect Control Hosp Epidemiol , vol.27 , pp. 682-687
    • Binkley, S.1    Fishman, N.O.2    LaRosa, L.A.3
  • 9
    • 84862128157 scopus 로고    scopus 로고
    • The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum b-lactamase-producing bacteria in primary and secondary healthcare settings
    • Aldeyab MA, Harbarth S, Vernaz N et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum b-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clinical Pharmacol 2012; 74: 171-9.
    • (2012) Br J Clinical Pharmacol , vol.74 , pp. 171-179
    • Aldeyab, M.A.1    Harbarth, S.2    Vernaz, N.3
  • 10
    • 84859592534 scopus 로고    scopus 로고
    • High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK
    • Wickramasinghe NH, Xu L, Eustace A et al. High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK. J Antimicrob Chemother 2012; 67: 1108-13.
    • (2012) J Antimicrob Chemother , vol.67 , pp. 1108-1113
    • Wickramasinghe, N.H.1    Xu, L.2    Eustace, A.3
  • 11
    • 20544434124 scopus 로고    scopus 로고
    • Minimising antibiotic resistance
    • Livermore DM. Minimising antibiotic resistance. Lancet Infect Dis 2005; 5: 450-9.
    • (2005) Lancet Infect Dis , vol.5 , pp. 450-459
    • Livermore, D.M.1
  • 13
    • 84926460137 scopus 로고    scopus 로고
    • PHE. Standards for Microbiology Investigations. http://www.hpa.org.uk/ProductsServices/MicrobiologyPathology/UKStandardsForMicrobiology Investigations/TermsOfUseForSMIs/AccessToUKSMIs/.
    • Standards for Microbiology Investigations
  • 16
    • 0032580320 scopus 로고    scopus 로고
    • Two-sided confidence intervals for the single proportion: comparison of seven methods
    • Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17: 857-72.
    • (1998) Stat Med , vol.17 , pp. 857-872
    • Newcombe, R.G.1
  • 17
    • 84889087805 scopus 로고    scopus 로고
    • Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK
    • Thomas CP, Moore LSP, Elamin N et al. Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. Int J Antimicrob Agents 2013; 42: 531-6.
    • (2013) Int J Antimicrob Agents , vol.42 , pp. 531-536
    • Thomas, C.P.1    Moore, L.S.P.2    Elamin, N.3
  • 18
    • 58249094505 scopus 로고    scopus 로고
    • Decontamination of the digestive tract and oropharynx in ICU patients
    • De Smet AMGA, Kluytmans JAJW, Cooper BS et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360: 20-31.
    • (2009) N Engl J Med , vol.360 , pp. 20-31
    • De Smet, A.M.G.A.1    Kluytmans, J.A.J.W.2    Cooper, B.S.3
  • 19
    • 77649109107 scopus 로고    scopus 로고
    • Ecological effects of selective decontamination on resistant Gram-negative bacterial colonization
    • Oostdijk EAN, de Smet AMGA, Blok HEM et al. Ecological effects of selective decontamination on resistant Gram-negative bacterial colonization. Am J Respir Crit Care Med 2010; 181: 452-7.
    • (2010) Am J Respir Crit Care Med , vol.181 , pp. 452-457
    • Oostdijk, E.A.N.1    de Smet, A.M.G.A.2    Blok, H.E.M.3
  • 20
    • 84875616502 scopus 로고    scopus 로고
    • Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis
    • Daneman N, Sarwar S, Fowler RA et al. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 328-41.
    • (2013) Lancet Infect Dis , vol.13 , pp. 328-341
    • Daneman, N.1    Sarwar, S.2    Fowler, R.A.3
  • 22
    • 78651269361 scopus 로고    scopus 로고
    • The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia
    • Shime N, Kosaka T, Fujita N. The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2010; 29: 1475-9.
    • (2010) Eur J Clin Microbiol Infect Dis , vol.29 , pp. 1475-1479
    • Shime, N.1    Kosaka, T.2    Fujita, N.3
  • 23
    • 84867334790 scopus 로고    scopus 로고
    • Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection. Antimicrobial Stewardship: Start Smart-Then Focus. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215308/dh_131181.pdf.
    • Antimicrobial Stewardship: Start Smart-Then Focus
  • 24
    • 84864917381 scopus 로고    scopus 로고
    • Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus
    • Ashiru-Oredope D, Sharland M, Charani E et al. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus. J Antimicrob Chemother 2012; 67 Suppl 1: i51-63.
    • (2012) J Antimicrob Chemother , vol.67 , pp. i51-i63
    • Ashiru-Oredope, D.1    Sharland, M.2    Charani, E.3
  • 25
    • 84858278979 scopus 로고    scopus 로고
    • Fourteen years in resistance
    • Livermore DM. Fourteen years in resistance. Int J Antimicrob Agents 2012; 39: 283-94.
    • (2012) Int J Antimicrob Agents , vol.39 , pp. 283-294
    • Livermore, D.M.1
  • 26
    • 33747065605 scopus 로고    scopus 로고
    • Impact of diversity of antibiotic use on the development of antimicrobial resistance
    • Sandiumenge A, Diaz E, Rodriguez A et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother 2006; 57: 1197-204.
    • (2006) J Antimicrob Chemother , vol.57 , pp. 1197-1204
    • Sandiumenge, A.1    Diaz, E.2    Rodriguez, A.3
  • 27
    • 84862699119 scopus 로고    scopus 로고
    • The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection
    • Ginn AN, Wiklendt AM, Gidding HF et al. The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection. PLoS One 2012; 7: e38719.
    • (2012) PLoS One , vol.7
    • Ginn, A.N.1    Wiklendt, A.M.2    Gidding, H.F.3
  • 28
    • 4444220133 scopus 로고    scopus 로고
    • Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals
    • Bergstrom CT, Lo M, Lipsitch M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci USA 2004; 101: 13285-90.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 13285-13290
    • Bergstrom, C.T.1    Lo, M.2    Lipsitch, M.3
  • 29
    • 79955410853 scopus 로고    scopus 로고
    • Evaluating the efficacy of antimicrobial cycling programmes and patient isolation on dual resistance in hospitals
    • Chow K,Wang X, Curtiss R et al. Evaluating the efficacy of antimicrobial cycling programmes and patient isolation on dual resistance in hospitals. J Biol Dyn 2011; 5: 27-43.
    • (2011) J Biol Dyn , vol.5 , pp. 27-43
    • Chow, K.1    Wang, X.2    Curtiss, R.3
  • 30
    • 80052647822 scopus 로고    scopus 로고
    • Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE organisms
    • Sandiumenge A, Lisboa T, Gomez F et al. Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE organisms. Chest 2011; 140: 643-51.
    • (2011) Chest , vol.140 , pp. 643-651
    • Sandiumenge, A.1    Lisboa, T.2    Gomez, F.3
  • 31
    • 84867023885 scopus 로고    scopus 로고
    • Antibiotic heterogeneity optimizes antimicrobial prescription and enables resistant pathogen control in the intensive care unit
    • Piper GL, Kaplan LJ. Antibiotic heterogeneity optimizes antimicrobial prescription and enables resistant pathogen control in the intensive care unit. Surg Infect (Larchmt) 2012; 13: 194-202.
    • (2012) Surg Infect (Larchmt) , vol.13 , pp. 194-202
    • Piper, G.L.1    Kaplan, L.J.2
  • 32
    • 84864276755 scopus 로고    scopus 로고
    • Resistance surveillance studies: a multifaceted problem-the fluoroquinolone example
    • Dalhoff A. Resistance surveillance studies: a multifaceted problem-the fluoroquinolone example. Infection 2012; 40: 239-62.
    • (2012) Infection , vol.40 , pp. 239-262
    • Dalhoff, A.1
  • 35
    • 84878855575 scopus 로고    scopus 로고
    • The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance
    • Ghafur A, Mathai D, Muruganathan A et al. The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer 2013; 50: 71-3.
    • (2013) Indian J Cancer , vol.50 , pp. 71-73
    • Ghafur, A.1    Mathai, D.2    Muruganathan, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.